Characteristics of patient samples
| . | Total (n = 213) . |
|---|---|
| Median age (range; n = 189) | 64 (31-84) |
| Male (%) | 160/211 (76) |
| Performance status >1 (%) | 35/176 (20) |
| Blastoid (%) | 20/212 (9) |
| MIPI (%) | |
| Low | 59/138 (43) |
| Intermediate | 34/138 (25) |
| High | 45/138 (33) |
| Treatment | |
| R-CHOP | 147 |
| Observation | 39 |
| Other | 5 |
| Unknown | 22 |
| HSCT/AUTO | 14 |
| . | Total (n = 213) . |
|---|---|
| Median age (range; n = 189) | 64 (31-84) |
| Male (%) | 160/211 (76) |
| Performance status >1 (%) | 35/176 (20) |
| Blastoid (%) | 20/212 (9) |
| MIPI (%) | |
| Low | 59/138 (43) |
| Intermediate | 34/138 (25) |
| High | 45/138 (33) |
| Treatment | |
| R-CHOP | 147 |
| Observation | 39 |
| Other | 5 |
| Unknown | 22 |
| HSCT/AUTO | 14 |
MCL tumor samples from 213 patients were obtained from patients living in British Columbia.
MIPI, MCL International Prognostic Index.